Writing

Boston startup AlterEgo launches the world's first wearable that reads subvocal muscle signals to enable silent communication at the speed of thought, bypassing traditional speech entirely.

Once a soda ingredient, lithium is now shown by Harvard to naturally support brain health and counter Alzheimer’s, signaling a bold shift toward nutrient-based neuroprotection.

AbbVie invests $1.2B in bretisilocin, a next-generation psychedelic therapy for depression, marking a leap where a few guided sessions could deliver months-long relief.

Eight Sleep secures $100M in Series D funding to transform AI-powered smart mattresses into tools for health monitoring, signaling a bold step where health-informed sleep data meets personalized care.

FDA-approved cancer drugs show strong promise in reversing Alzheimer’s—opening exciting new treatment possibilities and hope for patients.

Sam Altman-backed startup stirs excitement with ambitious plans and strong funding to develop high-speed brain-computer interfaces, hinting at a bold new future for human-AI interaction.